Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
Latest from News
The Senate on Monday approved on final reading a bill creating the Presidential Merit Scholarship Program
The Land Transportation Office (LTO) revoked the driver’s license of the person operating an SUV marked
The Philippine Statistics Authority (PSA) testified that the list of supposed informants paid from Vice President
SM Supermalls has reached its 500th job fair milestone, connecting around 330,000 jobseekers with employment opportunities
The number of leptospirosis cases in Manila has exceeded the epidemiologic threshold, with cases rising from